167 related articles for article (PubMed ID: 30689868)
1. Systemic investigation of bone and muscle abnormalities in dystrophin/utrophin double knockout mice during postnatal development and the mechanisms.
Gao X; Tang Y; Amra S; Sun X; Cui Y; Cheng H; Wang B; Huard J
Hum Mol Genet; 2019 May; 28(10):1738-1751. PubMed ID: 30689868
[TBL] [Abstract][Full Text] [Related]
2. Increased Expression of FGF-21 Negatively Affects Bone Homeostasis in Dystrophin/Utrophin Double Knockout Mice.
Li H; Sun H; Qian B; Feng W; Carney D; Miller J; Hogan MV; Wang L
J Bone Miner Res; 2020 Apr; 35(4):738-752. PubMed ID: 31800971
[TBL] [Abstract][Full Text] [Related]
3. Impaired bone defect and fracture healing in dystrophin/utrophin double-knockout mice and the mechanism.
Gao X; Sun X; Amra S; Cui Y; Deng Z; Cheng H; Zhang GW; Huard CA; Wang B; Huard J
Am J Transl Res; 2020; 12(9):5269-5282. PubMed ID: 33042418
[TBL] [Abstract][Full Text] [Related]
4. Activation of non-myogenic mesenchymal stem cells during the disease progression in dystrophic dystrophin/utrophin knockout mice.
Sohn J; Lu A; Tang Y; Wang B; Huard J
Hum Mol Genet; 2015 Jul; 24(13):3814-29. PubMed ID: 25859011
[TBL] [Abstract][Full Text] [Related]
5. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
[TBL] [Abstract][Full Text] [Related]
6. Dystrophin and utrophin "double knockout" dystrophic mice exhibit a spectrum of degenerative musculoskeletal abnormalities.
Isaac C; Wright A; Usas A; Li H; Tang Y; Mu X; Greco N; Dong Q; Vo N; Kang J; Wang B; Huard J
J Orthop Res; 2013 Mar; 31(3):343-9. PubMed ID: 23097179
[TBL] [Abstract][Full Text] [Related]
7. Increasing muscle contractility through low-frequency stimulation alters tibial bone geometry and reduces bone strength in
Chan AS; Hardee JP; Blank M; Cho EH; McGregor NE; Sims NA; Lynch GS
J Appl Physiol (1985); 2023 Jul; 135(1):77-87. PubMed ID: 37262103
[TBL] [Abstract][Full Text] [Related]
8. Treatment with the anti-IL-6 receptor antibody attenuates muscular dystrophy via promoting skeletal muscle regeneration in dystrophin-/utrophin-deficient mice.
Wada E; Tanihata J; Iwamura A; Takeda S; Hayashi YK; Matsuda R
Skelet Muscle; 2017 Oct; 7(1):23. PubMed ID: 29078808
[TBL] [Abstract][Full Text] [Related]
9. Analysis of gene expression differences between utrophin/dystrophin-deficient vs mdx skeletal muscles reveals a specific upregulation of slow muscle genes in limb muscles.
Baker PE; Kearney JA; Gong B; Merriam AP; Kuhn DE; Porter JD; Rafael-Fortney JA
Neurogenetics; 2006 May; 7(2):81-91. PubMed ID: 16525850
[TBL] [Abstract][Full Text] [Related]
10. The role of Notch signaling in muscle progenitor cell depletion and the rapid onset of histopathology in muscular dystrophy.
Mu X; Tang Y; Lu A; Takayama K; Usas A; Wang B; Weiss K; Huard J
Hum Mol Genet; 2015 May; 24(10):2923-37. PubMed ID: 25678553
[TBL] [Abstract][Full Text] [Related]
11. Muscle structure influences utrophin expression in mdx mice.
Banks GB; Combs AC; Odom GL; Bloch RJ; Chamberlain JS
PLoS Genet; 2014 Jun; 10(6):e1004431. PubMed ID: 24922526
[TBL] [Abstract][Full Text] [Related]
12. Skeletal muscle fibrosis in the mdx/utrn+/- mouse validates its suitability as a murine model of Duchenne muscular dystrophy.
Gutpell KM; Hrinivich WT; Hoffman LM
PLoS One; 2015; 10(1):e0117306. PubMed ID: 25607927
[TBL] [Abstract][Full Text] [Related]
13. Aberrant RhoA activation in macrophages increases senescence-associated secretory phenotypes and ectopic calcification in muscular dystrophic mice.
Mu X; Lin CY; Hambright WS; Tang Y; Ravuri S; Lu A; Matre P; Chen W; Gao X; Cui Y; Zhong L; Wang B; Huard J
Aging (Albany NY); 2020 Dec; 12(24):24853-24871. PubMed ID: 33361519
[TBL] [Abstract][Full Text] [Related]
14. Bone is functionally impaired in dystrophic mice but less so than skeletal muscle.
Novotny SA; Warren GL; Lin AS; Guldberg RE; Baltgalvis KA; Lowe DA
Neuromuscul Disord; 2011 Mar; 21(3):183-93. PubMed ID: 21256750
[TBL] [Abstract][Full Text] [Related]
15. Systemic delivery of human bone marrow embryonic-like stem cells improves motor function of severely affected dystrophin/utrophin-deficient mice.
Pang RQ; He J; Zhang YY; Xiong F; Ruan GP; Zhu XQ; Wang Q; Wang JX; Zhu GX; Zhao J; Cai XM; Pan XH; Zhang C
Cytotherapy; 2014 Dec; 16(12):1739-49. PubMed ID: 25442501
[TBL] [Abstract][Full Text] [Related]
16. Utrophin deficiency worsens cardiac contractile dysfunction present in dystrophin-deficient mdx mice.
Janssen PM; Hiranandani N; Mays TA; Rafael-Fortney JA
Am J Physiol Heart Circ Physiol; 2005 Dec; 289(6):H2373-8. PubMed ID: 16024571
[TBL] [Abstract][Full Text] [Related]
17. Prevention of the dystrophic phenotype in dystrophin/utrophin-deficient muscle following adenovirus-mediated transfer of a utrophin minigene.
Wakefield PM; Tinsley JM; Wood MJ; Gilbert R; Karpati G; Davies KE
Gene Ther; 2000 Feb; 7(3):201-4. PubMed ID: 10694796
[TBL] [Abstract][Full Text] [Related]
18. BGP-15 Improves Aspects of the Dystrophic Pathology in mdx and dko Mice with Differing Efficacies in Heart and Skeletal Muscle.
Kennedy TL; Swiderski K; Murphy KT; Gehrig SM; Curl CL; Chandramouli C; Febbraio MA; Delbridge LM; Koopman R; Lynch GS
Am J Pathol; 2016 Dec; 186(12):3246-3260. PubMed ID: 27750047
[TBL] [Abstract][Full Text] [Related]
19. Dystrophin and utrophin expression require sarcospan: loss of α7 integrin exacerbates a newly discovered muscle phenotype in sarcospan-null mice.
Marshall JL; Chou E; Oh J; Kwok A; Burkin DJ; Crosbie-Watson RH
Hum Mol Genet; 2012 Oct; 21(20):4378-93. PubMed ID: 22798625
[TBL] [Abstract][Full Text] [Related]
20. Utrophin influences mitochondrial pathology and oxidative stress in dystrophic muscle.
Kennedy TL; Moir L; Hemming S; Edwards B; Squire S; Davies K; Guiraud S
Skelet Muscle; 2017 Oct; 7(1):22. PubMed ID: 29065908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
